Trial intelligence / Profile preview

Adhesion study of ZTlido vs Lidoderm and Versatis in healthy volunteers

NCT04320173Phase 1Completed

Sponsor
Scilex Holding
Start
Feb 2017
Primary completion
Mar 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of lidocaine topical system in postherpetic neuralgia (PHN) (3 arms), sponsored by Scilex Holding. Primary endpoints: Mean Adhesion Score (FDA scale) and Mean Adhesion Score (EMA scale). Started Feb 2017; status: completed.

02

Drugs

lidocaine topical system
03

Conditions

postherpetic neuralgia (PHN)

Beyond the preview

Go deeper on NCT04320173.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04320173.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call